巨子生物:双 11 旗下品牌高增长 4.69%

和讯网
27 Nov 2024

【巨子生物早盘上涨 4.69%,现报 51.30 港元,成交额 1.32 亿港元】浦银国际发布研报称,2024 年“双 11”期间,巨子生物旗下两大品牌可复美及可丽金再次实现高增长。 据公司“双 11”战报,可复美与可丽金线上全渠道 GMV 分别同比增长 80%+和 150%+。可复美高速增长,且较今年“618”增速提升。 该行持续看好重组胶原蛋白行业及公司化妆品产品高速增长,认为公司两大品牌“双...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10